Transplantation

Article	Citations
T-cell Immunometabolism: Therapeutic Implications in Organ Transplantation	144
The Challenges of Risk Aversion in Kidney Transplantation: Lessons From the SARS-CoV-2 Pandemic in Brazil	137
Research Highlights	105
Variations in Swine Liver Anatomy	104
Virtual and Reality: An Analysis of the UCLA Virtual Crossmatch Exchanges	100
Outcomes of Coccidioides Seropositive Solid Organ Transplant Recipients After Self-discontinuation of Antifungal Prophylaxis: The EIA-IgM-only Conundrum	78
Coronary Computed Tomography Angiography in Heart Transplant Patients: Current Insights and Future Directions	74
Ethical Considerations in Nonconsenting Adult Allogeneic Stem Cell Donors	72
The Presence of Donor-specific Antibodies Around the Time of Pancreas Graft Biopsy With Rejection Is Associated With an Increased Risk of Graft Failure	67
BAASIS for Monitoring Therapy Nonadherence in Clinical Transplantation: Are We There Yet?	67
The Case for Prolonged ECMO for COVID-19 ARDS as a Bridge to Recovery or Lung Transplantation	66
Report of the Standardized Outcomes in Nephrology-transplant Consensus Workshop on Establishing a Core Outcome Measure for Infection in Kidney Transplant Recipients	64
Distinct Outcomes of Kidney Transplant Recipients With Recent COVID-19 According to the Timing of Infection	63
Targeting Kidney Inflammation After Brain Death and Cold Storage: Investigating the Potential of an NLRP3 Inflammasome Inhibitor (MCC950) for Preconditioning Donor Kidneys	61
Dr Andreas Gerasimos Tzakis, MD, PhD, Dhc (mult), Professor of Surgery, Emeritus Director of Transplantation, Cleveland Clinic	61
Solid Organ Transplantation From Deceased Donors With Infective Endocarditis: The UK Experience	58
Disparities in Access to Kidney Transplantation in Developing Countries	57
76: Non-vascularized Abdominal Rectus Fascia for abdominal closure after transplantation, single center report and long-term follow-up	55
O-46: Cost-utility of Kitelock in Preventing Central Line-associated Blood Stream Infections in Children with Intestinal Failure: A Markov Model	52
46: The fall of a myth: the first three cases of DCD in intestinal transplantation	52
P-17: Transplant Associated Thrombotic Microangiopathy and Immune Haematological Complications Following Intestine Containing Organ Transplantation: Experience from Over 100 Consecutive Cases	51
PE-23: Reversal of Treatment-refractory Malabsorption after Resection of Jejunal Diverticulosis: A Case Series	50
P-19: Intestinal Failure Associated Liver Disease in Paediatric Patients Underwent Intestinal Lengthening Surgery for Short Bowel Syndrome	50
P-85: Quality of Life in Patients in Home Parenteral Nutrition in Brazil	48
P-38: Use of Lactase Enzyme for Control of Diarrhea in Patients Breast Fed with Short Bowel Syndrome	48

PE-17: Blockage of PD-L1 Expression in Intestinal Graft Accelerates Allogeneic Immune Response in Mice	48
P-27: Results of Ernica* Survey on Food Introduction in Infants with Short Bowel Syndrome Managed by Specialist Intestinal Failure Rehabilitation Centres	47
P-94: The Need for Social Care Support in Children Pre- and Post-Intestiinal Transplant, A Case Series	45
PE-20: Development of a Consensus Parenteral Nutrition Weaning Algorithm for Paediatric Patients with Short-bowel Syndrome Responding to Teduglutide Therapy	41
O-05: Ghrelin in Children with Intestinal Failure Receiving Long-term Parenteral Nutrition	40
*O-30: Stoma-output Reinfusion Device for Ileostomy Patients: A Feasibility Study	39
P-51: Successful Central Venous Catheter Salvage after Central Line Associated Blood Stream Infections(CLABSI) in Children on Long-term Home Parenteral Nutrition(PN)	39
PE-1: “Line Care Governs Our World”: Understanding the Lived Experience of Caregivers of Children with Intestinal Failure on Long-term Parenteral Nutrition	39
P-39: Health Care Costs Associated with Australian Home Parenteral Nutrition	38
P-60: Single Centre Experience of Paediatric Intestinal Transplantation During the COVID-19 Pandemic: Lessons from Adapting to Pandemic Pressures	37
PE-12: Role of B-cell Subsets in Allograft Rejection in Intestinal Transplantation	37
PE-21: Assessment of Moderate and Severe Intestinal Failure Associated Liver Disease. Clinical, Analytical and Histological Correlation	36
P-66: Adequate Exposure to Tacrolimus with Sublingual Administration	36
O-49: The First Five Years of the New Zealand National Intestinal Failure & Rehabilitation Service	36
O-14: Portal Hypertensive Complications after Pediatric Combined Liver-intestine Transplantation from Late Vascular Compromise of Native Portacaval Shunt: Clinical Presentation and Management	34
Creation of the ILTS Consensus Statements on DCD and Liver Perfusion: Defining the Future of Liver Transplantation by Returning to the Past	33
P-23: Isolated Liver Transplant as a Rescue in Children with End-stage Intestinal Failure-Associated Liver Disease	32
Antibody-mediated Rejection and the Graft Endothelium in Solid Organ Transplantation	32
PE-24: Intestinal Failure Associated Liver Disease and Acute on Chronic Liver Failure: An Entity of Increased Mortality	32
B-cell Deficiency Attenuates Transplant Glomerulopathy in a Rat Model of Chronic Active Antibody-mediated Rejection	30
Major Thromboembolic Complications in Liver Transplantation: The Role of Rotational Thrombelastometry and Cryoprecipitate Transfusion	30
O-28: Comprehensive Gut Rehabilitation and Transplantation for Gut Failure in Crohn’s Disease: Evolving Role of Serial Transverse Enteroplasty	30
Characteristics and Donation Outcomes of Potential Organ Donors Perceived to Be at Increased Risk for Blood-borne Virus Transmission: An Australian Cohort Study 2010–2018	30
Research Highlights	29
Research Highlights	28
O-39: Comparison of the Effects of Normothermic Machine Perfusion and Cold Storage Preservation on Porcine Intestinal Allograft Regenerative Potential and Viability	28
Serum Glycomics, a Novel Biomarker That Opens Doors to a Better Understanding of Graft Failure	28
O-25: A Single-Center, Detailed Report of Malignancies Following Intestinal Transplantation	28
Hepatobiliary Scintigraphy to Increase the Safety in Right Lobe Living Donor Liver Transplantation: Not Just a Matter of Age and Remnant Volume	28
Graft-derived Cell-free DNA: Twilight Years of the Endomyocardial Biopsy?	28
Pneumocystis jirovecii: The Changing Landscape for Prophylaxis	28
P-73: Non-invasive Monitoring of Intestinal Allograft Function	27
O-26: Pre- and Peri-transplant Factors Impacting Frequency of Endoscopy after Intestinal Transplantation	27
PE-27: Long-term Nutritional Status in Pediatric Small Bowel Transplantation	27
O-40: Single-Cell Immune Profiling of Human Intestinal Allografts Reveals Differential Contributions of HvG T-cell Clones in Quiescent vs Chronically Rejecting Allografts	27
P-31: Real World Experience and 12 Month Outcomes for Patients Treated with Teduglutide at an Australian Centre	27
P-11: Epidemiology and Clinical Outcomes of Chronic Intestinal Failure Patients Undergoing Home Parenteral Nutrition, Experience from A Brazilian Intestinal Rehabilitation Center	27
104: Conversion from SMOFlipid® to Omegaven® as a Salvage Therapy for Severe Intestinal Failure Associated Liver Disease	26
152: Painful hands in a multi visceral transplant patient	26
The Costs of Organ Procurement: Another Case of Efficiency Versus Equity	26
57: Protective effect of the GLP-2 analogue on intestinal ischemia-reperfusion injury in mice	26
31: The Impact of Colonic Allograft on Intestinal Transplantation Outcomes: Results from UNOS/OPTN Database	25
153: Eculizumab as a treatment for early antibody mediated liver rejection in a multivisceral transplant patient	25
1: Impact of food intake on the efficacy of Teduglutide treatment in adult patients with short bowel syndrome	25
17: Early infections after intestinal transplantation in adults. A comparison with liver transplantation.	25
136: Intestinal Transplant in patients with multiple FAP complicated by intraabdominal desmoid tumor: A Case Series	25
111: Surgical Techniques for non-Short Bowel Syndrome Children with Intestinal Failure: Reducing Length and Improving Outcome.	25
121: Preliminary experience with Ultrasound of the intestine- a non-invasive tool for acute rejection	24
19: Indications and Success of Intestinal Transplantation in European Children	24
59: Outcomes of patients with paediatric intestinal failure and Serum Bilirubin >100umol/L referred for intestinal transplantation- Are current guidelines appropriate?	24

26: Inflammasome Activation Involved in the Early Inflammation following Intestinal Transplantation: Implications in Acute Rejection	24
32: 30-year experience of children with Intestinal Failure Associated liver disease	24
48: Luminal Preservation of the Human Intestine with a Polyethylene Glycol Solution Applicable for Transplantation.	24
Abstracts	23
Alloreactive Tissue-resident Memory T Cells in Solid Organ Transplantation: Do They Light the Fire?	23
ILTS 2022 Joint International Congress of ILTS, ELITA & LICAGE, May 4-7, 2022	23
Equivalence of Pediatric Paper and Electronic-based Patient-reported Outcome Measures: Findings From a Systematic Review	23
When the Deceased Donor Has Sustained Blunt Trauma to the Liver: What Happens Next?	23
Immediate Extubation Following Pediatric Liver Transplantation	23
47: 10 Years’ Experience of Transplant Oncology in the Management of Unresectable Desmoid Tumor: One-staged or Two-staged Approach	23
Preexisting Coronary Artery Disease in Liver Transplant Candidates: Risk Factor or Risk Marker?	23
Bernard Charpentier, MD	22
Amplified Natural Killer Cell Activity and Attenuated Regulatory T-cell Function Are Determinants for Corneal Alloimmunity in Very Young Mice	22
Perfusate Enzymes and Platelets Indicate Early Allograft Dysfunction After Transplantation of Normothermically Preserved Livers	22
Overcoming Challenges of Deceased Organ Donation in Indian Private Hospitals	22
Letter Regarding: Women Leadership in Liver Transplantation—Results of an International Survey	22
Many a Slip Twixt the Intake Form and the Living Donation	22
The Effect of the COVID-19 Pandemic in Intestinal Rehabilitation and Transplant Patients: Initial Results of the Intestinal Rehabilitation and Transplant Association’s International Survey	21
Opportunities and Challenges of Targeting an Aging Immune System	21
The Future Is Now: OrganEx Technology and Its Implications for Transplant Medicine	21
Negative COVID-19 Plasma PCR Following COVID-19+ Donor Kidney Transplant	21
Research Highlights	21
Unanswered Questions on the Management of Nocardia Infections in Transplant Recipients	21
Dysbiosis of the Female Murine Gut Microbiome Exacerbates Neutrophil-mediated Vascular Allograft Injury by Affecting Immunoregulation by Acetate	21
Comment to “Donor Simvastatin Treatment in Liver Transplantation: Post-hoc Analysis of a Randomized Placebo-controlled Trial With Long-term Follow-up”	21
Single-Cell Immunoprofiling Technologies in and Beyond Solid Organ Transplantation	20
Radiological Classification of Distinct Patterns of Nonanastomotic Strictures: Can We Predict the Course of the Disease?	20
Organ Donation From a Brain Dead Donor With Vaccine-induced Immune Thrombotic Thrombocytopenia After Ad26.COV2.S: The Risk of Organ Microthrombi	20
The Destiny of Articles When Pairing “Traditional”—With Open Access Sibling Journals	20
First Case of Successful Urgent Liver Retransplantation Using a Graft From a Donor After Uncontrolled Circulatory Death	20
Research Highlights	20
Incorporation of Sex and Gender Guidelines Into Transplantation Literature	20
Multicenter Matched-pair Analysis of Extended Right Lobe Versus Whole Organ Liver Transplantation: A Snap Shot of the Tragic Situation in Germany	20
Vaccination for HAV: A Lesson From Acute Hepatitis A Superinfection on Chronic B Hepatitis With Lifesaving Living Donor Liver Transplantation for Hepatic Failure	20
307.1: Bionic Pancreas - The First Results of Functionality Bionic Tissue Model With Pancreatic Islets	19
A New Look at an Old Problem: Is Single Lung Transplantation an Option in Candidates With Significant Secondary Pulmonary Hypertension?	19
The Ferret Era of Experimental Lung Transplantation Is Upon Us	19
Research Highlights	19
Letter to the Editor	19
Starting at the Source: Donor Research, Done Right	19
One Biomarker to Diagnose Them All?	19
The Delay of Arterialization After Initial Portal Reperfusion More Than Warm Ischemia Time May Determine Ischemic-type Biliary Injury	19
307.8: Novel Approach in Pancreatic Islet Transplantation: Acellular Vessel	18
306.2: Comparison of Incidence of Solid Cancers After Islet or Combined Kidney-Whole Pancreas Transplantation	18
P.171: Long-term Study of Vascularized Pancreas-on-chip	18
P.143: Higher Patient Mortality in Type 2 2020 Simultaneous Pancreas/Kidney (SPK) Transplants - A Preliminary Registry Analysis	18
207.5: Impact of HLA Donor Specific Antibodies in the Era of Cell Therapy: Clinical Trajectories in Islet Allotransplantation Illustrate a Challenging Model	18
P.133: Systemic Venous Versus Portal Venous Drainage in Simultaneous Pancreas-Kidney Transplantation: A Matched-pair Analysis	17
209.3: Treating iPSC-derived β Cells With Monoclonal Antibody Brentuximab Reduces the Risk of Teratoma Upon Transplantation	17
82: Teduglutide in 19 pediatric SBS patients – single center real world data on clinical efficacy and treatment associated challenges	17
209.1: Co-localized Immune Protection Using Cyclosporine A Eluting Micelles in a Murine Islet Allograft Model	17
P.113: The Role of Necroptosis in Beta-cell Loss Following Islet Cell Transplantation	17
P.149: Extracellular Vesicles From Patients With Diabetic Nephropathy Induce Endothelial Dysfunction Through ICAM-1 and VCAM-1 in an In Vitro Model	17
97: ENDOSCOPIC AND SURGICAL APPROACH IN PATIENT WITH INTESTINAL FAILURE WITH LIFE-THREATENING GASTROINTESTINAL BLEEDING	17
209.4: Characterizing the Therapeutic Potential of Human Pluripotent Stem Cell-derived Islet-like Cells Lacking Cell-Surface HLA Expression	17
80: Nutritional status of intestinal transplant recipients: one year follow-up data from a UK adult transplant centre	17
306.5: A Prospective Study of Donor-specific Anti-HLA Antibody Monitoring in Pancreas Transplantation	17
P.162: Enhancing Islet Allotransplantation With Antioxidant-based Encapsulation Strategies	16
Sex-based Disparities in Hepatocellular Carcinoma Recurrence After Liver Transplantation	16
Biomarkers for Chronic Lung Allograft Dysfunction: Ready for Prime Time?	16
P.145: Retroperitoneal Pancreas Transplantation With High Duodenojejunal Anastomosis on a Roux-en-Y Loop	16
306.6: Importing Pancreata for Transplantation: An 18-year Single Center Experience	16
Re: Hepatobiliary Scintigraphy to Increase the Safety in Right Lobe Living Donor Liver Transplantation: Not Just a Matter of Age and Remnant Volume	16
P7.10: A Phase 1, Open-Label Evaluation of the Pharmacokinetics And Safety of a Single Dose of Apraglutide in Subjects With Normal and Impaired Renal Function	16
P.169: Decellularized Cotyledons Isolated From Human Placenta Used Like a Scaffold for the Generation of a Human Bioartificial Pancreas	16
P.130: Achilles Heel No Longer: Marked Decline in Early Relaparotomy and Allograft Pancreatectomy Rates Following Simultaneous Kidney-Pancreas Transplantation in the Contemporary Era	16
Ribavirin to the Rescue: Natural Killer–Cell Function After Hepatitis C Virus Treatment in Liver Transplant Recipients	16
P-74: Change in CMV Infection Rates Over Time at a UK Transplant Centre	16
Response to Letter-to-the-Editor	16
406.2: Utility of Donor-derived Cell-free DNA in Assessing Simultaneous Pancreas-Kidney Transplantation Rejection	16
P2.11: Distinct Global DNA Methylation and NF-κB Expression Profile of Preimplantation Biopsies From Ideal and Non-ideal Kidneys	15
P8.129: Description of the Process of Inclusion and Kidney Transplantation Waiting List - Uruguay	15
P8.141: Prevalence and Outcome of Kidney Transplant Recipients Infected With BK Polyoma Virus at National Kidney And Transplant Institute From 2016 to 2021	15
P11.16: Quality Monitoring Indicators in the Process of Organ And Tissue Donation for Transplantation: A Scoping Review Preliminary Results	15
P8.081: Differential Control of Systolic and Diastolic Blood Pressure in Renal Transplant Recipients	15
P16.21: Impact of Vaccination Against SARS-CoV-2 in Kidney Transplant Recipients	15
P8.079: Systematic Review and Meta-Analysis on the Effect of Blood Transfusions on Kidney Transplant Outcomes: Shining New Light on an Age-Old Debate	15
P8.036: Late Humoral Rejection: Will Temporality Be Enough To Determine the Therapeutic Attitude?	15
P6.01: Actuarial Perspective on the Immunosuppressive Medication Costs and Coverage for Transplant Recipients in the Argentine´S Public System: 2009-2021	15
P12.15: Dapagliflozin for the Treatment of Post-transplant Diabetes Mellitus After Pancreas Transplantation: A Case Report With A 14-Month Follow-up	15

425.4: The Role of Role of Sex and T Cells in Natural vs Induced ABO Antibody Production in Mice	15
P5.12: Education of Medical Students on Organ Donation and Transplantation	15
P16.16: Seroconversion in Liver and Intestine Transplant Patients After One, Two or Three Doses of Adenoviral Vector Vaccines Against SARS-CoV-2. Single Center Experience in Argentina	15
P11.30: Influence of Basic Cardiopulmonary Reanimation on Uncontrolled Donors After Cardiac Death	15
423.4: Raising the Potential of Transplantation With a KPD Collaborative Program	15
P9.09: Peri-Hepatic Gauze Packing for the Control of Haemorrhage During Liver Transplantation: Experience of a High-Volume Center	14
P13.13: Pediatric Transplant and SARS COV2 in a Country With High Lethality	14
P9.40: Liver Transplantation for Secondary Hemophagocytic Lymphohistiocytosis Associated Acute Liver Failure: A Case Report	14
P8.115: Polyomavirus Infection in the Urine for Follow-up of Renal Transplant Patient: A Single Center Study	14
P17.02: Towards Bionic Organs: Biocompatibility of Newly Developed Porcine dECM-Based Hydrogels	14
P8.148: HLA Desensitization in Kidney Transplantation	14
P8.042: Non-melanoma Skin Cancer With an Aggressive Course in Kidney Transplant Patients Treated With Rapamycin	14
P8.102: Teratoma in Transplanted Patient, Case Report and Review	14
P11.17: Sustaining Life After Brain Death During Pregnancy: A Case Report	14
P14.16: Acute and Chronic Allograft Rejection in the Uruguayan Lung Transplant Program in the 2003 – 2022 Period	14
P11.19: System-Level Barriers to Living Donor Kidney Transplantation: A Cross-Sectional Survey Study of Health Professionals	14
P13.09: Biliary Atresia: Intention-To-Treat Analysis in a Pediatric Liver Transplant Center	14
P5.15: Build-up on School Education Program to Nurture the Value of Sharing and Deceased Organ Donation for Youth in Korea	14
P17.07: Comparison of Graft Survival Between Full Thickness And Lamellar Pig-To-Monkey Corneal Xenotransplantation From the Same Genetically Engineered Pig With Minimal Immunosuppression	14
P9.49: Efficacy and Long-term Prognosis of Liver Transplantation For Porto-Pulmonary Hypertension	14
P17.09: CD27-Expressing Xenoantigen-Expanded Human Regulatory T Cells Are Efficient in Suppressing Xenogeneic Immune Response	14
P16.38: Healthcare Resource Utilization in Transplant Recipients With Cytomegalovirus Infection Refractory to Prior Treatment With/Without Resistance Receiving Maribavir Versus Investigatorassigned Th	14
P4.02: Performance of the Hypotension Prediction Index in Living Donor Liver Transplant Recipients: A Prospective Observational Study	14
210.3: Safe Living Kidney Donor Transplantation During the COVID-19 Pandemic: Experience From the Singapore General Hospital.	14
P10.03: Alternative Surgical Techniques for Abdominal Wall Graft Donation to Guarantee Abdominal Wall Closure in the Donor	14
P8.142: Perturbations in Podocyte Transcriptome and Biological Pathways Induced by Injury Caused by FSGS Associated Circulating Factors	14
P8.003: Post-transplant Diabetes de NOVO (NODAT) in a Paraguayan Kidney Transplant Population: Prevalence and Risk Factors	14
215.3: Prediction of Post-transplant Hospitalization Among Kidney Transplant Recipients With Clinical Notes and Electronic Healthcare Record Data	13
216.12: Pretransplant Micrornas in Liver Perfusate Associate With Early Allograft Dysfunction	13
211.7: Is Pulse Oximetry a Good Screening Test for Hepatopulmonary Syndrome in Liver Transplant Candidates?	13
216.16: The Association Between Regulatory T Cell Subpopulations and Severe Pneumonia Post Renal Transplantation	13
210.10: Seroconversion After Vaccination With BNT162b2 Pfizer/BioNTech, ChAdOx1 nCoV-19/AZD1222 and Coronavac Against Sars-cov-2 Among Hemodialysis and Kidney Transplant Patients	13
211.16: Effect on Kidney Transplant Allocation With the Implementation of Concentric Circles Liver Allocation Policy: Impact of Simultaneous Liver Kidney Transplantation	13
248.11: Torque Teno virus Load as Functional Marker of Immune Function in Solid Organ Transplantation: A Systematic Review And Meta-Analysis	13
314.12: The Outcomes of Renal Transplantation During the COVID-19 Pandemic. Is It Worth Doing?	13
213.3: Long-term Outcome and Complications in Pediatric ABO-incompatible Living Donor Kidney Transplantation With rituximab Induction: A Multi-centre Investigation From the Nordic Paediatric Renal Tra	13
247.7: Trends and Risk Factors for Mortality While Awaiting Heart Transplantation: A UNOS Registry Analysis	13
210.2: Impact of mRNA COVID-19 Vaccination on Clinical Outcomes of COVID-19 Infection in Kidney Transplant Recipients at the Singapore General Hospital	13
215.12: Renal Handling of Phosphorus Very Early After Kidney Transplantation in Adults	13
234.8: Donor-Derived Cell-Free DNA for Rejection Surveillance in Simultaneous Pancreas Kidney Transplantation	13
241.11: Successful Islet After Pancreas and Pancreas After Islet Transplantation for Patients With Diabetes Mellitus and Problematic Hypoglycemia	13
247.3: Utility of Liver Biopsy in Liver Transplantation: Implications for Changes in Liver Allocation	13
210.17: Bacterial and Viral Infections After Kidney Transplant Before and After the COVID-19 Pandemic	13
249.10: COVID-19 Infection in Liver Transplant Recipients: Results From a Brazillian Multicentric Historical Cohort	13
240.5: Parvovirus B19 Disease Post-renal Transplant Presenting as Refractory Anemia - Case Series of 20 Patients	13
211.5: Long-term Experience of Liver Transplant Combined With Other Organs: A Single Center Analysis	13
214.4: The Genetic Epidemiology of Hereditary Pancreatitis in Australia and Its Effect on Patients of Total Pancreatectomy and Islet Auto Translation (TP-IAT)	13
212.6: Heart Transplantation Using Donation After Circulatory Death Donors – an 8 Year Experience	13
216.14: Validating a Cut-off of IgG Hypogammaglobulinemia as a Risk Factor of Severe Infection in Solid Organ Transplantation	13
314.1: Response to a Pandemic: The Fall and Rise of Kidney Transplantation in the United States	13
342.2: Sodium-Glucose Co-transporter 2 Inhibitors (SGLT2i); Shortterm Outcome in Diabetic Kidney Transplant Recipients	12
234.5: Portal-Endocrine and Gastric-Exocrine Drainage Technique in Pancreas Transplantation	12
246.3: MicroRNA Tests for Complex Diagnostic of Acute Rejection And Bacterial Infection After Heart Transplantation	12
337.8: The Dynamic of Physical Capacity and Quality of Life in Recipients After Heart Transplantation	12
343.6: Outcomes of Simultaneous Kidney-Pancreas Transplantation in Patients With Type-1 and Type-2 Diabetes Mellitus	12
343.9: Longitudinal Monitoring of Pancreas and Kidney Transplant Recipients Using Donor-Derived Cell-Free DNA	12
345.8: Professional Employment in Patients on Ventricular Assist Device Support – A Multi-Center Prevalence Study	12
233.3: Organ Trafficking: The Portuguese Experience in Developing A Legal Framework and a Protocol of Conduct for Health Professionals for the Management of Patients Who Receive an Organ Transplant Ab	12
310.9: Ultra-Short Duration Pangenotypic Direct Acting Anti-viral Prophylaxis to Prevent Virus Transmission From Hepatitis C Viremic (HCV) Donors to Hepatitis C Negative Kidney Transplant Recipients	12
333.5: Osteopenia Predicts Posttransplant Survival Among Livingdonor Liver Transplant Recipients	12
401.1: Impact of HLA-A,B DR and DQ on Living Kidney Transplant Outcomes in the Tacrolimus/MMF Era: An Artificial Intelligence Approach	12
248.1: Hepatitis B virus Status of Organ Donors in Argentina	12
247.2: Advancing Towards an Equitable Access of Transplantation in Latin American and Caribbean Sub-Region	12
236.8: Early Surgical Complications in Everolimus (EVR) Treated Renal Transplant Recipients	12
230.4: COVID-19 Mortality in Vaccinated vs. Unvaccinated Solid Organ Transplant Recipients: A Single Center United States Propensity Score Matching Study	12
316.7: ABO – Incompatible Kidney Transplantation in COVID 19 Era: A Single Centre Experience	12
340.11: Flow Cytometric Pattern of Gamma Delta TCR Expression Identifies Outcomes in Kidney Transplantation	12
246.5: How Much Is Too Much? Determining the Optimal Oxygen Concentration for Early Hypothermic Oxygenation of Liver Grafts in Rodents	12
244.3: External Validation of the Toulouse-Rangueil Predictive Model to Estimate Donor Renal Function After Living Donor Nephrectomy	12
244.6: Postoperative Health Status and Quality of Life After Pure Laparoscopic Donor Hepatectomy for Living Donor Liver Transplantation	12
213.6: Arterial Stiffness and Changes in Blood Pressure: Longitudinal Analyses in Pediatric Kidney Transplant Recipients	12
236.9: Robotic Versus Open Mini-Incision Living Donor Nephrectomy: Single Center Experience	11
214.9: Pancreas Transplants in the Elderly Patient - How Far Can We Go?	11
313.11: Association of Hemoglobin Levels With Renal Metabolism and Function During Normothermic Machine Perfusion of Porcine Kidneys	11
335.5: Has the Risk of Liver Re-Transplantation Improved Over the Two Decades? A UNOS Data Analysis	11
342.9: Factors Associated With a Higher Need for Antihypertensive Medications at 12- Months Post Renal Transplantation	11
414.10: Cytokine Analysis of First Gal-KO Renal Xenotransplantation From a Pig-To-Human Recipient	11
313.3: Domino Kidney Transplant Following Nephrectomy for Renal Artery Stenosis With Arterial Reconstruction and Viability Assessment Using Ex Vivo Normothermic Perfusion: A Case Series	11
231.5: Anti-CD40L Antibody Promotes the Differentiation of Vy2+ Regulatory Gamma-delta T Cells and Prolongs the Survival of Skin Allografts	11
240.7: Macrophages and Different Subtypes Infiltrated in Kidney Allografts With Antibody-Mediated Rejection	11
248.2: Cellular Immunity Test and Risk for Cytomegalic Disease in Kidney Transplants	11
237.4: Diversity in Organ Donation in Scotland - Improving Awareness in Black and Ethnic Minority Groups	11
242.3: Is Kidney Time-Zero Biopsy Useful to Predict Graft Function at 1-Year?	11
427.5: Clinical Validation of a Plasma Donor-Derived Cell-Free DNA Assay to Detect Allograft Rejection and Injury in Lung Transplant	11
313.5: Meeting Packed Red Blood Cell Requirement for the Transmedics Organ Care System (OCS) Liver Transplantation Trial (PROTECT Trial) At Henry Ford Hospital	11
237.1: ODISSeA: Organ Donation Innovative Strategies For Southeast Asia	11
248.10: COVID-19 Infections in Pediatric Renal Transplant Recipients	11
236.4: Implanting a Robot-Assisted Kidney Transplant Program For Transplant Surgeons With No Robotic Surgery Background	11
242.9: Do the Findings of Pre-transplant Cardiovascular Imaging Corollate With Having Persistent Hyperparathyroidism at Year Post Renal Transplantation?	11
247.9: Liver Transplantation from Discarded Liver Grafts. A Useful Policy for Expanding the Liver Donor Pool in Mexico	11
424.12: Donor-Derived Acute Hepatitis a Virus Infection in Two Kidney Transplant Recipients From a Common Donor	11
411.2: Rejection After Liver Transplantation: What Can We Learn From Transcriptomic Analysis?	11
417.2: Equal Outcome and Fewer Complications With Azathioprine Compared to Mycophenolate in Pediatric First-Time Kidney Transplantation: Should Current Practice Be Re-Evaluated?	10
316.1: Incidence and Effect on Survival of Delayed Graft Function in Donor-Deceased Kidney Transplants in Argentina: A Multicenter Analysis	10
341.10: Disparity in Access to Kidney Transplantation in the Province of Buenos Aires, Argentina	10